Environmental Risk Assessment Framework for Pharmaceuticals
Calculate pharmaceutical environmental risk quotients against ICH M7 regulatory standards
What You Can Do
You can structure complete environmental risk assessments for pharmaceutical submissions by organizing ecotoxicity study data, calculating predicted environmental concentrations and predicted no-effect concentrations across aquatic/terrestrial/sediment compartments, and deriving risk quotients. This determines whether your drug requires Phase I (desktop) or Phase II (comprehensive) assessment, accelerates regulatory timelines, and identifies data gaps before expensive studies are commissioned.
Features
compile and validate OECD guideline study results (acute/chronic fish, daphnia, algae, terrestrial species) against completeness checklists
model environmental concentrations using dose, metabolism, elimination, and wastewater treatment assumptions with transparent assumptions logging
establish predicted no-effect concentrations from study data using species sensitivity distributions, assessment factors, and uncertainty adjustments
calculate PEC/PNEC ratios for each environmental compartment and identify concern thresholds triggering Phase II testing
structure findings against ICH M7 decision trees and regulatory classification (Class 1–5) for ecotoxicity hazards
apply read-across and QSAR predictions to assess environmental hazards of active metabolites with justification frameworks
recommend manufacturing controls, formulation changes, or post-market monitoring to reduce environmental exposure
generate sections ready for IND/CTA/NDA/MAA submissions with standardized tables and narrative structures
Example Output
Example 1: Phase I Risk Characterization Output
| Compartment | Study Data | PEC (μg/L) | PNEC (μg/L) | RQ | Classification |
|---|---|---|---|---|---|
| Aquatic (Fish) | 96h LC50: 45 mg/L | 0.8 | 0.45 | 1.78 | Phase II Required |
| Sediment | 28d Chironomid: 12 mg/kg | 2.1 | 3.2 | 0.66 | Phase I Complete |
Recommendation: Conduct fish early life stage study (OECD 210) to refine PEC calculation and reduce uncertainty factor from 100 to 50.
Example 2: Metabolite Assessment
Active metabolite M7 (20% human AUC exposure): QSAR-predicted fish LC50 = 15 mg/L (Cramer Class II). PEC 0.6 μg/L. RQ = 0.04 (acceptable under Phase I). Read-across to structural analog justified by metabolic stability data.
Example 3: Regulatory Summary for NDA
Environmental Hazard Classification: ICH M7 Class 3 (possible concern). Environmental Risk Quotient: 0.82 (Phase I adequate). Conclusion: No Phase II studies required; post-market monitoring recommended for long-term aquatic effects.
What's Included
- SKILL.md: complete ERA workflow instruction file with ICH M7 decision logic, PEC/PNEC calculation templates, and compliance checklists
- Ecotoxicity Data Compilation Checklist: OECD guideline completeness matrix (fish, daphnia, algae, terrestrial, sediment species)
- PEC/PNEC Calculation Worksheets: step-by-step templates for aquatic, sediment, and terrestrial compartment modeling with assumption documentation
- Risk Quotient Summary Table: standardized format for Phase I/II classification and regulatory decision mapping
- Metabolite Assessment Framework: read-across justification template, QSAR applicability checklist, and hazard uncertainty guidance
Who It's For
- Regulatory Affairs Toxicologists — structure and execute environmental risk assessments for IND/NDA/MAA submissions
- R&D Environmental Safety Scientists — plan Phase I/II testing scope and identify data gaps early in development
- Pharmaceutical Project Managers — estimate regulatory timelines and study costs based on risk classification
- Preclinical CRO Managers — design ecotoxicity study proposals aligned with regulatory requirements
- Quality/Compliance Professionals — document environmental hazard determination for manufacturing approvals and post-market surveillance
Best For
- Environmental hazard characterization for regulatory dossiers (IND, CTA, NDA, MAA)
- Phase I/II risk classification and determination of required study scope
- PEC/PNEC calculation and risk quotient derivation across environmental compartments
- Ecotoxicity dataset synthesis and completeness gap identification
- Metabolite environmental hazard assessment using read-across and QSAR data
You might also like
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
This skill generates comprehensive fault study reports, protection coordination analyses, and compliance documentation for electrical power systems. It systematically documents fault scenarios, relay settings, coordination curves, and technical specifications required for grid operations and regulatory compliance. You produce production-ready documentation that meets industry standards—IEEE, NERC, and regional RTO requirements.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
Analyze your PLC code and ladder logic to identify logic errors, safety violations, and inefficiencies before they reach production. You'll get detailed diagnostics of control system failures, safety compliance verification against IEC 61131 standards, and optimization recommendations for automation sequences. This skill helps you prevent costly downtime, ensure worker safety, and improve system performance across manufacturing operations.
by kody-w
You can translate raw variant catalogs and NGS data into actionable target hypotheses by synthesizing variant effect predictions, population frequency metrics, disease association evidence, and protein interaction networks. This skill automates the connection between molecular findings and clinical relevance, producing comprehensive variant assessments that justify target selection across pharmaceutical development stages and support regulatory submissions.
by kody-w
Create comprehensive tool specifications tailored to your manufacturing process, material combinations, and performance requirements. Analyze cutting speeds, feeds, tool life, and thermal behavior to predict tool performance and identify optimization opportunities. You can compare design alternatives, predict failure modes, and generate compliance documentation for production tooling decisions.
by kody-w
You can prepare complete site monitoring visit documentation, including source document verification (SDV) checklists tailored to specific case report forms, comprehensive findings reports from visit notes, and structured data query forms for identified discrepancies. This skill standardizes compliance documentation, identifies protocol deviations systematically, and creates actionable remediation plans to maintain data integrity and GCP compliance across investigator sites.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w